Kenji Suzuki is an Associate professor at the Department of Electrical and Computer Engineering and Medical Imaging Research Center, Illinois Institute of Technology, Chicago, Illinois, USA

Medical Imaging Research

Dr. Brij. M. Gandhi, M.Sc.(Biochemistry) and Ph.D.(Experimental Medicine, Norway) is presently CEO and founder of Neo BioMed Services (www.neobiomed.com), providing services and consultancy in health areas and regulatory issues related to biopharmaceuticals, pharmaceuticals, including stem cell and regenerative medicine. As Adviser to the Government of India, Dr. Gandhi was involved in management, promotion and policy issues in biotechnology related to international collaborations, medical biotechnology, infrastructure development, animals and aquaculture biotechnology, biosafety and biosecurity. Prior to that he was Research Scientist at AIIMS, New Delhi working on immunology of parasitic,bacterial and viral infections including amoebic diseases; hepatitis; liver diseases, IVD, food and nutritional health issues. Dr. Gandhi was trained at MIT, USA; LSHTM, London, NIH, USA, Hvidovre Hospital, Copenhagen and University of Bergan, Norway. Dr. Gandhi continues to serve as Advisor / Director to a number of institutions/pharma and biopharma industries with an experience of about 50 years as research scientist, science manager, adviser/consultant and having over 155 publications.

Biopharmaceuticals, Pharmaceuticals

Dr. Yanping Zhang, Professor in the Department of Radiation Oncology and Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, USA, received his B.S. and M.S. degrees from Fudan University in China, and Ph.D. degree from the University of Nebraska at Lincoln, USA. Dr. Zhang performed post-graduate training at UNC Chapel Hill, and he became a tenure-track Assistant Professor at the M. D. Anderson Cancer Center in Texas in 2000. Dr. Zhang moved his laborator to UNC Chapel Hill in 2004, where he moved his rank to full professor in 2010. Dr. Zhang has made important contributions to cancer research through many groundbreaking works about tumor suppressor p53. His work has been published in high-impact journals such as Cell, Science, Cancer Cell, Molecular Cell, and PNAS, etc.,

Radiation Oncology, Cancer